Companies
Are Akebia Therapeutics Inc. (NASDAQ:AKBA)’s Fundamentals Enough to Outperform
Akebia Therapeutics Inc. (NASDAQ:AKBA) has a beta of 1.74. The stock’s Relative Strength Index (RSI) is 58.34, with weekly volatility at 5.07% and ATR at
Akebia Therapeutics Inc. (NASDAQ:AKBA) has a beta of 1.74. The stock’s Relative Strength Index (RSI) is 58.34, with weekly volatility at 5.07% and ATR at
Akebia Therapeutics Inc. (NASDAQ:AKBA) Relative Strength Index (RSI) is 62.90, with weekly volatility at 4.56% and ATR at 0.18. The AKBA stock’s 52-week price range
Akebia Therapeutics Inc. (NASDAQ:AKBA) previous close was $3.33 while the outstanding shares total 153.82M. The firm has a beta of 1.74. AKBA’s shares traded higher
Akebia Therapeutics Inc. (NASDAQ:AKBA) has a beta of 1.75. The stock’s Relative Strength Index (RSI) is 58.46, with weekly volatility at 4.39% and ATR at
Discover high-quality information at your convenience with ‘State Reviewer.’ Our news portal offers valuable insights for free, available in accessible locations such as metro stations, busy intersections, cafes, and business centers. Wherever your day takes you, ‘State Reviewer’ ensures you’re never out of touch with the latest news and updates.
All rights reserved © 2024, Powered by Smart TechOne